ISORYTHM L.P. 125 mg, extended-release capsule 20 capsules
Active ingredients: Disopyramide, Disopyramide phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule20 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ISORYTHM L.P. 125 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 20 gélule(s)
- Marketing authorisation holder
- SERP
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Aug 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66198796CIP73298939CIP133400932989393Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DISOPYRAMIDE (PHOSPHATE DE)gélule | 161,08 mg · une gélule | SA |
| DISOPYRAMIDEgélule | 125 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.